Jason Hoitt

Jason Hoitt

Chief Patient OfficeratStoke Therapeutics· In the 2025 proxy

Pay in FY2025Stoke Therapeutics stock +187.8% the same year

Jason Hoitt was paid $2.3M in FY2025 (Dec). Stoke Therapeutics stock rose 187.8% that year.

Pay$100 in the stock at the end of FY24 → $288
Pay is from the Summary Compensation Table of each Stoke Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Stoke TherapeuticsPublic company · 1 yr
    • Chief Patient Officer2025 – Present · 1 yrStock in role +133%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?